Immunome, Inc.
USD19.34
-1.44 (-6.93%)
CEO
Clay Siegall
IPO Date
2020-10-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$20.36
Prev. Close
$20.78
Day Low
$19.19
Day High
$20.68
52W Low
$7.96
52W High
$27.65
Market Cap
$1.85B
Volume
2.79M
| 9,438 |
| $21.64 |
| 3 Apr 2026 | Rosett Max | Chief Financial Officer | M-Exempt | Acquired | 31,848 | $1.05 |
| 3 Apr 2026 | Rosett Max | Chief Financial Officer | M-Exempt | Acquired | 39,713 | $1.35 |
| 3 Apr 2026 | Rosett Max | Chief Financial Officer | S-Sale | Disposed | 63,656 | $21.91 |
| 3 Apr 2026 | Rosett Max | Chief Financial Officer | S-Sale | Disposed | 1,344 | $22.48 |
| 3 Apr 2026 | Rosett Max | Chief Financial Officer | M-Exempt | Disposed | 31,848 | $1.05 |
| 3 Apr 2026 | Rosett Max | Chief Financial Officer | M-Exempt | Disposed | 39,713 | $1.35 |
| 1 Apr 2026 | Higgins Jack | Chief Scientific Officer | G-Gift | Disposed | 6,291 | $0.00 |
| 31 Mar 2026 | SIEGALL CLAY B | director, officer: President and CEO | P-Purchase | Acquired | 25,450 | $19.67 |